Skip to content
Search

Latest Stories

UK launches Critical Imports Council to secure supplies of medicines, smartphone chips

UK launches Critical Imports Council to secure supplies of medicines, smartphone chips

The Council aims to address the supply challenges businesses face and develop real-life solutions

The UK government has intensified efforts to safeguard supplies of vital goods such as medicines and smartphone chips by introducing a Critical Imports Council today (April 17).

Comprising of 23 industry leaders, the newly formed Council will advise on “securing resilience in supply chains for items critical to the UK’s economic prosperity, national security and essential services.”


The Association of British Healthtech Industries (ABHI), the Association of the British Pharmaceutical Industry (ABPI), British Generic Manufacturers Association (BGMA) are among the members of the Council.

According to the Department for Business and Trade (DBT), the council is an extension of the government’s Critical Imports and Supply Chains Strategy launched in January.

“It will allow business and government to work together in implementing the Strategy’s 18 actions – ensuring businesses have a central voice in shaping government’s work to build supply chain resilience,” DBT said.

Alan Mak, the minister for business and trade and chair of the Critical Imports Council, underscored the importance of strengthening supply chains to ensure the uninterrupted delivery of essential goods to consumers amidst challenges such as the COVID-19 pandemic, the Red Sea attacks and various other global crises.

“That’s why we’re now going even further to strengthen our critical goods supplies with the launch of this new Council, which will bring together government and industry experts to help protect businesses from supply chain shocks now and in the future,” he said.

Richard Torbett, CEO of ABPI, emphasised the crucial role of supporting and safeguarding the resilient supply of medicines and vaccines to the NHS for the wider health and wealth of UK citizens.

He said: “I look forward to working with others to maintain and further improve the UK’s robust and responsive medicines supply.”

Working with the government, the Council aims to address the supply challenges businesses face and develop real-life solutions.

They will meet quarterly, and collaborate on emerging supply chain risks and identify the support UK businesses need to reduce vulnerabilities in supply chains.

As per the Department for Business and Trade's announcement, an online portal will be created for businesses to report instances of red tape or supply chain issues, facilitating prompt action to address these issues.

Members of the Critical Imports Council include:

  1. ADS Group
  2. Association of British Healthtech Industries
  3. Association of the British Pharmaceutical Industry
  4. BAE Systems
  5. BASF
  6. British Chambers of Commerce
  7. British Generic Manufacturers Association
  8. BT
  9. Chemical Business Association
  10. Cranfield School of Management
  11. Critical Minerals Association
  12. Institute of Export and International Trade
  13. Tech UK
  14. Institute of Materials, Minerals and Mining
  15. Johnson Matthey
  16. Logistics UK
  17. Make UK
  18. Maritime UK
  19. Renewable UK
  20. Rolls-Royce
  21. Society of Motor Manufacturers and Traders (SMMT)
  22. UK Chambers of Shipping
  23. UK Trade Policy Observatory

A group of health charities and community pharmacists has recently warned that the ongoing drug shortage crisis in the UK will put more patients’ health at risk if the issues in the medicines supply chain are not promptly addressed.

They stressed the need for “openness and transparency” between the government and manufacturers to resolve medicine shortages.

Medicine shortages in the UK have doubled over the past two years, with BGMA figures indicating that there were 101 reported drug supply issues in February 2024 compared to 52 in February 2022.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less